[December 15, 2017] |
|
U.S. Dulera Promotional Activity Report 2016-2017 - Research and Markets
The "Dulera
2016 U.S Promotional Report" report has been added to Research
and Markets' offering.
The 5 Key Questions Addressed by this Report:
-
How many physicians were reached by Dulera through personal promotion
in 2016 and how does this compare to its peer set in the Asthma
markets?
-
What promotional mix was leveraged (e.g., sales rep detailing,
physician education, and paid speaking) and what was the median spend
on each type of activity?
-
How does Merck's depth of coverage vary within key specialties (e.g.,
Family Medicine, Internal Medicine, Pulmonology, Allergy/Immunology,
and Pediatric Medicine) and how does this compare to its peers and the
overall set of rep-accssible physicians?
-
How often are physicians receiving paid meals for Dulera throughout
the year (e.g., monthly, quarterly, annually)?
-
Who were the most detailed prescribers and top paid speakers for
Dulera in 2016?
Data Sources and Methodology:
-
We leverage company-reported financial transaction data disclosed
through CMS Open Payments. This data set captures all transfers of
value (e.g., speaking fees, consulting fees, travel, education, and
meals) made on behalf of a drug or device manufacturer to a physician.
Currently, 42 months of longitudinal data is available - covering
payments to more than 900,000 U.S. healthcare professionals.
-
Over 35,300 paid interactions across 18,900 physicians made on behalf
of Dulera were carefully examined to support our analysis. In
addition, interaction data from 13 peer products (e.g. Advair,
Aerospan, Arnuity, Asmanex, Breo, Cinqair, Flovent, Nucala, ProAir,
Qvar, Spiriva, Symbicort, and Xolair) was leveraged to provide
benchmarking and market insights.
For more information about this report visit https://www.researchandmarkets.com/research/bcxfl7/u_s_dulera?w=4
View source version on businesswire.com: http://www.businesswire.com/news/home/20171215005509/en/
[ Back To TMCnet.com's Homepage ]
|